Thanks for posting this andius. I have a feeling someone else also posted it a few weeks ago. As you say the 45 mg per day was referring to Crinone 4 % gel - so all of you who are rushing to reduce your dose - this is not comparable to the utrogestan formulation - just as utrogestan is not comparable either to Cyclogest where generally double the dose is prescribed ( again off licence for HRT).
So PLEASE do not think this gives you license to experiment as you please - but discuss any change in regime with your doctor and make sure you have regular scans for anything less than the licensed dose.
I'm not sure actually that the article reports any new studies but as it is a systematic review - brings together all the published information on vaginal progesterone - but as I said you cannot compare Crinone gel with utrogestan/Prometrium. Unfortunately as often the case with these papers - only the abstract is published and you have to pay quite a lot of money to view one article ( approx $35 - which is a bit steep for something that ought to be publically available!).
I reproduced some of the abstracts and some research preivously on the Utrogestan/Estrogel thread - maybe I should start a separate thread so it can be easily found?
Here is the information about Crinone:
Vaginal progesterone in menopause: Crinone® 4% in cyclical and constant combined regimens
D.de Ziegler124, R.Ferriani3 , L.A.M.Moraes3 , and C.Bulletti4
Human Reproduction, Vol. 15, (Suppl. 1), pp. 149-158, 2000
https://humrep.oxfordjournals.org/content/15/suppl_1/149.full.pdfCompliance with hormone replacement therapy (HRT) is notoriously low despite ample documentation of clinical efficacy. The two major reasons given by women who discontinue HRT are uterine bleeding and side-effects. The recent development of a controlled and sustained vaginal progesterone gel allowed single daily application and made prolonged use such as for menopause possible. Here we report our clinical experience with two therapeutic options for HRT using natural progesterone administered vaginally. A first group of 69 menopausal women received the sustained release vaginal progesterone gel, Crinone® 4% (45 mg daily) from days 1-10 of each calendar month with oestrogens taken continuously. A second group of 67 women received Crinone 4% twice weekly in conjunction with continuous oestrogen therapy. Endometrial thickness was evaluated before and after 6 months of treatment. Histological verification was obtained in all cases of abnormal bleeding. At 6 months, 63 out of 69 (91.9%) women receiving progesterone cyclically experienced predictable withdrawal bleeding. The vast majority, 54 (80.6%) of 67 women receiving Crinone in constant combined association with oestrogen therapy, remained amenorrhoeic throughout 6 months of therapy. AH cases of abnormal bleeding were biopsied and no hyperplasia was seen. Our results indicate that both regimens using the sustained release vaginal progesterone gel controlled bleeding in HRT. Combined with the lower incidence of side-effects characteristic of vaginal progesterone, both vaginal progesterone regimens have the potential of improving HRT compliance.I don't know of anyone currently using it but I know someone on here has tried it - who is extremely prog intolerant, but the side effects were too severe for her to continue.
It's great that recommendations are appearing but of course there are a lot of ifs and buts..... perhaps women should ask for Crinone to have a go - but of course being unlicensed, probably more difficult to get than utrogestan.
Hurdity x